Umb Bank, N.A. Cytokinetics Inc Transaction History

Umb Bank, N.A.

$5.92 Billion
Q1 2025

A detailed history of Umb Bank, N.A. transactions in Cytokinetics Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 1,156 shares of CYTK stock, worth $35,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,156

Previous 604 91.39%

Holding current value

$35,859

Previous $28,000 75.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$40.19 - $51.12 $22,184 - $28,218	552 Added 91.39%	1,156 $49,000
Q4 2024 Jan 16, 2025	BUY	$46.36 - $58.62 $139 - $175	3 Added 0.5%	604 $28,000
Q3 2024 Oct 08, 2024	BUY	$51.22 - $60.16 $12,190 - $14,318	238 Added 65.56%	601 $31,000
Q2 2024 Jul 29, 2024	SELL	$47.86 - $75.05 $287 - $450	-6 Reduced 1.63%	363 $19,000
Q1 2024 Apr 26, 2024	BUY	$63.75 - $108.06 $1,530 - $2,593	24 Added 6.96%	369 $25,000
Q4 2023 Jan 23, 2024	SELL	$26.88 - $83.49 $1,585 - $4,925	-59 Reduced 14.6%	345 $28,000
Q4 2021 Feb 09, 2022	BUY	$34.35 - $46.38 $13,877 - $18,737	404 New	404 $18,000

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $2.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account